95 related articles for article (PubMed ID: 2295503)
1. Epithelial membrane antigen staining of melanocytic nevi.
Cramer SF
Hum Pathol; 1990 Jan; 21(1):121-2. PubMed ID: 2295503
[No Abstract] [Full Text] [Related]
2. Evaluation of human monoclonal antibody (2-139-1) in cutaneous melanocytic neoplasms in fixed tissue sections.
White WL; Tam ST; Mitchell MS; Yu MC; Kan-Mitchell J
J Histochem Cytochem; 1991 Jun; 39(6):777-85. PubMed ID: 1709658
[TBL] [Abstract][Full Text] [Related]
3. Growth dynamics of acquired melanocytic nevi. Higher reactivity of proliferating cell nuclear antigen in junctional and compound nevi than intradermal nevi.
Tokuda Y; Saida T; Mukai K; Takasaki Y
J Am Acad Dermatol; 1994 Aug; 31(2 Pt 1):220-4. PubMed ID: 7913717
[TBL] [Abstract][Full Text] [Related]
4. Update on immunohistochemistry in melanocytic lesions.
Ferringer T
Dermatol Clin; 2012 Oct; 30(4):567-79, v. PubMed ID: 23021046
[TBL] [Abstract][Full Text] [Related]
5. Antigens associated with tumor progression in melanocytic neoplasia.
Elder DE; Herlyn M
Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
[No Abstract] [Full Text] [Related]
6. Differential expression of MART-1 in primary and metastatic melanoma lesions.
Kageshita T; Kawakami Y; Hirai S; Ono T
J Immunother; 1997 Nov; 20(6):460-5. PubMed ID: 9409451
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: primary and metastatic melanoma and halo and giant pigmented nevi.
Edelson RL; Hearing VJ; Dellon AL; Frank M; Edelson EK; Green I
Clin Immunol Immunopathol; 1975 Nov; 4(4):557-68. PubMed ID: 1081937
[No Abstract] [Full Text] [Related]
8. Epithelial distribution of a myelomonocytic antigen LI in relation to cutaneous malignancies and melanocytic naevi.
Gabrielsen TO; Brandtzaeg P; Hoel PS; Dale I
Br J Dermatol; 1988 Jan; 118(1):59-67. PubMed ID: 3277660
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characterization of Spitz's nevus: differentiation from common melanocytic nevus, dysplastic melanocytic nevus and malignant melanoma.
Takahashi H; Maeda K; Maeda K; Akutsu Y; Horikoshi T; Jimbow K
J Dermatol; 1987 Dec; 14(6):533-41. PubMed ID: 3329652
[No Abstract] [Full Text] [Related]
10. [Immuno-diagnosis of malignant melanoma].
Szekeres G; Battyáni Z
Magy Onkol; 2003; 47(1):45-50. PubMed ID: 12704454
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of HLA antigens and lymphocyte infiltration in melanocytic tumors.
Kageshita T; Nagano H; Johno M; Ono T; Arao T; Imai K
J Dermatol; 1986 Jun; 13(3):179-84. PubMed ID: 3537044
[No Abstract] [Full Text] [Related]
12. Desmoplastic melanocytic nevi with lymphocytic aggregates.
Kiuru M; Patel RM; Busam KJ
J Cutan Pathol; 2012 Oct; 39(10):940-4. PubMed ID: 22845683
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi or melanoma.
Mitchell MS; Nordlund JJ; Lerner AB
J Invest Dermatol; 1980 Aug; 75(2):144-7. PubMed ID: 7410884
[No Abstract] [Full Text] [Related]
14. [Delayed hypersensitivity reaction in malignant melanoma].
Gorodilova VV; Saraeva ZM; Slesareva RI; Monzul' GD
Vopr Onkol; 1973; 19(3):23-7. PubMed ID: 4762691
[No Abstract] [Full Text] [Related]
15. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
[No Abstract] [Full Text] [Related]
16. Antigenic phenotype of pigment cell lesions: a study of melanoma, its precursor lesions and heterogeneity in metastatic melanoma.
Ernstoff MS; Duray P; Stenn K; Kirkwood JM
J Invest Dermatol; 1985 May; 84(5):430-2. PubMed ID: 3889169
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous regression of multiple melanocytic nevi after melanoma: report of 3 cases.
Martín JM; Pinazo I; Monteagudo C; Markovic J; Allende A; Jordá E
Am J Dermatopathol; 2014 Nov; 36(11):e183-8. PubMed ID: 25343215
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
Kopera D; Hohenleutner U; Stolz W; Landthaler M
Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
[TBL] [Abstract][Full Text] [Related]
19. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
20. Halo nevus: competent surveillance of potential melanoma?
Krebs JA; Roenigk HH; Deodhar SD; Barna B
Cleve Clin Q; 1976; 43(1):11-5. PubMed ID: 1261030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
